Vaccine development in Staphylococcus aureus: Taking the biofilm phenotype into consideration

FEMS Immunology and Medical Microbiology

Volumn 59, Issue 3, 2010, Pages 306-323

  Harro, Janette M ^a   Peters, Brian M ^a,b   O'May, Graeme A ^a   Archer, Nathan ^a,b   Kerns, Patrick ^a,b   Prabhakara, Ranjani ^a,b   Shirtliff, Mark E ^a,b  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

biofilm; Staphylococcus aureus; vaccine

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; RECOMBINANT VACCINE; SUBUNIT VACCINE; STAPHYLOCOCCUS VACCINE;

ADJUVANT THERAPY; BACTERIAL GROWTH; BIOFILM; DRUG DEVELOPMENT; GENE EXPRESSION; GENOMICS; INNATE IMMUNITY; MIXED INFECTION; MUTAGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEOMICS; SEROLOGY; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; TRANSCRIPTOMICS; VACCINATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; STAPHYLOCOCCAL INFECTIONS;

ANTIGENS, BACTERIAL; BIOFILMS; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS;

EID: 77954637231     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2010.00708.x     Document Type: Short Survey

References (159)

1. Ambrosch F, Wiedermann G, Crooy P George AM (1983) Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine. B World Health Organ 61 : 317 323.
2. Ammendolia MG, Di Rosa R, Montanaro L, Arciola CR Baldassarri L (1999) Slime production and expression of the slime-associated antigen by staphylococcal clinical isolates. J Clin Microbiol 37 : 3235 3238.
3. Angelichio MJ Camilli A (2002) In vivo expression technology. Infect Immun 70 : 6518 6523.
4. Arciola CR, Baldassarri L Montanaro L (2001a) Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J Clin Microbiol 39 : 2151 2156.
5. Arciola CR, Collamati S, Donati E Montanaro L (2001b) A rapid PCR method for the detection of slime-producing strains of Staphylococcus epidermidis and S. aureus in periprosthesis infections. Diagn Mol Pathol 10 : 130 137.
6. Armand J, Arminjon F, Mynard MC Lafaix C (1982) Tetravalent meningococcal polysaccharide vaccine groups A, C, Y, W 135: clinical and serological evaluation. J Biol Stand 10 : 335 339.
7. Artenstein MS, Gold R, Zimmerly JG, Wyle FA, Schneider H Harkins C (1970) Prevention of meningococcal disease by group C polysaccharide vaccine. New Engl J Med 282 : 417 420.
8. Assenmacher M, Lohning M, Scheffold A, Manz RA, Schmitz J Radbruch A (1998) Sequential production of IL-2, IFN-gamma and IL-10 by individual staphylococcal enterotoxin B-activated T helper lymphocytes. Eur J Immunol 28 : 1534 1543.
9. Bakaletz LO (1995) Viral potentiation of bacterial superinfection of the respiratory tract. Trends Microbiol 3 : 110 114.
10. Bamford CV, d'Mello A, Nobbs AH, Dutton LC, Vickerman MM Jenkinson HF (2009) Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect Immun 77 : 3696 3704.
11. Bastos RG, Borsuk S, Seixas FK Dellagostin OA (2009) Recombinant Mycobacterium bovis BCG. Vaccine 27 : 6495 6503.
12. Beenken KE, Dunman PM, McAleese F et al 2004) Global gene expression in Staphylococcus aureus biofilms. J Bacteriol 186 : 4665 4684. (Pubitemid 38891030)
13. Bernatoniene J Finn A (2005) Advances in pneumococcal vaccines: advantages for infants and children. Drugs 65 : 229 255.
14. Brady RA, Leid JG, Camper AK, Costerton JW Shirtliff ME (2006) Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection. Infect Immun 74 : 3415 3426.
15. Brady RA, Leid JG, Kofonow J, Costerton JW Shirtliff ME (2007) Immunoglobulins to surface-associated biofilm immunogens provide a novel means of visualization of methicillin-resistant Staphylococcus aureus biofilms. Appl Environ Microb 73 : 6612 6619.
16. Brady RY, O'May G, Leid JG, Costerton JW Shirtliff ME (in press) Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment. Infect Immun, in press.
17. Brewer JM (2006) (How) do aluminium adjuvants work? Immunol Lett 102 : 10 15.
18. Brogden KA, Guthmiller JM Taylor CE (2005) Human polymicrobial infections. Lancet 365 : 253 255.
19. Brown MR, Allison DG Gilbert P (1988) Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemoth 22 : 777 780.
20. Bubeck Wardenburg J Schneewind O (2008) Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 205 : 287 294.
21. Buzas K, Megyeri K, Miczak A, Fekete A, Degre M, Mandi Y Rosztoczy I (2004) Different staphylococcal strains elicit different levels of production of T-helper 1-inducing cytokines. Acta Microbiol Immunol Hung 51 : 371 384.
22. Carlson E (1983) Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality and morbidity. Infect Immun 42 : 285 292.
23. Cerca N, Jefferson KK, Maira-Litran T et al 2007) Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun 75 : 3406 3413.
24. Chhatwal GS (2002) Anchorless adhesins and invasins of Gram-positive bacteria: a new class of virulence factors. Trends Microbiol 10 : 205 208.
25. Choi AH, Slamti L, Avci FY, Pier GB Maira-Litran T (2009) The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N- acetylglucosamine, which is critical for biofilm formation. J Bacteriol 191 : 5953 5963.
26. Costa AR, Henriques M, Oliveira R Azeredo J (2009) The role of polysaccharide intercellular adhesin (PIA) in Staphylococcus epidermidis adhesion to host tissues and subsequent antibiotic tolerance. Eur J Clin Microbiol 28 : 623 629.
27. Coulter SN, Schwan WR, Ng EY et al 1998) Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol Microbiol 30 : 393 404.
28. Cramton SE, Gerke C, Schnell NF, Nichols WW Gotz F (1999) The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun 67 : 5427 5433.
29. Cramton SE, Ulrich M, Gotz F Doring G (2001) Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun 69 : 4079 4085.
30. Dauwalder O, Thomas D, Ferry T et al 2006) Comparative inflammatory properties of staphylococcal superantigenic enterotoxins SEA and SEG: implications for septic shock. J Leukocyte Biol 80 : 753 758.
31. de Beer D, Stoodley P, Roe F Lewandowski Z (1994) Effects of biofilm structures on oxygen distribution and mass transport. Biotechnol Bioeng 43 : 1131 1138.
32. Decker MD Edwards KM (2000) Acellular pertussis vaccines. Pediatr Clin N Am 47 : 309 335.
33. DeLeo FR, Diep BA Otto M (2009) Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin N Am 23 : 17 34.
34. Didierlaurent AM, Morel S, Lockman L et al 2009) AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J Immunol 183 : 6186 6197.
35. Diebel LN, Liberati DM, Diglio CA, Dulchavsky SA Brown WJ (1999) Synergistic effects of Candida and Escherichia coli on gut barrier function. J Trauma 47 : 1045 1050.
36. Dyet KH Martin DR (2005) Sequence variation in the porB gene from B:P1.4 meningococci causing New Zealand's epidemic. J Clin Microbiol 43 : 838 842.
37. Dykes GA, Sampathkumar B Korber DR (2003) Planktonic or biofilm growth affects survival, hydrophobicity and protein expression patterns of a pathogenic Campylobacter jejuni strain. Int J Food Microbiol 89 : 1 10.
38. Ehrlich GD, Veeh R, Wang X et al 2002) Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA-J Am Med Assoc 287 : 1710 1715.
39. Ehrlich GD, Hiller NL Hu FZ (2008) What makes pathogens pathogenic. Genome Biol 9 : 225 225.7.
40. Erdos G, Sayeed S, Antalis P et al 2003) Development and characterization of a pooled Haemophilus influenzae genomic library for the evaluation of gene expression changes associated with mucosal biofilm formation in otitis media. Int J Pediatr Otorhi 67 : 749 755.
41. Eskola J, Kilpi T, Palmu A et al 2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. New Engl J Med 344 : 403 409. (Pubitemid 32128672)
42. Etz H, Minh DB, Henics T et al 2002) Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. P Natl Acad Sci USA 99 : 6573 6578.
43. Falkow S (1988) Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 10 (suppl 2) : S274 S276.
44. Fattom A, Fuller S, Propst M et al 2004) Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients. Vaccine 23 : 656 663.
45. Fattom AI, Sarwar J, Ortiz A Naso R (1996) A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect Immun 64 : 1659 1665.
46. Finne J, Leinonen M Makela PH (1983) Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 2 : 355 357.
47. Fleischmann RD, Adams MD, White O et al 1995) Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269 : 496 512.
48. Foster TJ (2005) Immune evasion by staphylococci. Nat Rev Microbiol 3 : 948 958.
49. Fountoulakis M Takacs B (2001) Effect of strong detergents and chaotropes on the detection of proteins in two-dimensional gels. Electrophoresis 22 : 1593 1602.
50. Fowler VG Jr., Fey PD, Reller LB, Chamis AL, Corey GR Rupp ME (2001) The intercellular adhesin locus ica is present in clinical isolates of Staphylococcus aureus from bacteremic patients with infected and uninfected prosthetic joints. Med Microbiol Immun 189 : 127 131.
51. Fraser A, Goldberg E, Acosta CJ, Paul M Leibovici L (2007) Vaccines for preventing typhoid fever. Cochrane Db Syst Rev 3 : CD001261.
52. Friedlander AM Little SF (2009) Advances in the development of next-generation anthrax vaccines. Vaccine 27 (suppl 4) : D28 D32.
53. Gatlin CL, Pieper R, Huang ST et al 2006) Proteomic profiling of cell envelope-associated proteins from Staphylococcus aureus. Proteomics 6 : 1530 1549.
54. Gening M, Maira-Litran T, Kropec A et al 2010) Synthetic β-(1>6)-linked N-acetylated and non-acetylated oligoglucosamines to produce conjugate vaccines for bacterial pathogens. Infect Immun 78 : 764 772.
55. Gilbert P, Maira-Litran T, McBain AJ, Rickard AH Whyte FW (2002) The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol 46 : 202 256.
56. Glowalla E, Tosetti B, Kronke M Krut O (2009) Proteomics-based identification of anchorless cell wall proteins as vaccine candidates against Staphylococcus aureus. Infect Immun 77 : 2719 2729.
57. Granoff DM (2010) Review of meningococcal group B vaccines. Clin Infect Dis 50 (suppl 2) : S54 S65.
58. Hagan EC Mobley HL (2007) Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun 75 : 3941 3949.
59. Hall-Stoodley L, Hu FZ, Gieseke A et al 2006) Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA-J Am Med Assoc 296 : 202 211.
60. Handfield M, Brady LJ, Progulske-Fox A Hillman JD (2000) IVIAT: a novel method to identify microbial genes expressed specifically during human infections. Trends Microbiol 8 : 336 339.
61. Hansson M, Nygren PA Stahl S (2000) Design and production of recombinant subunit vaccines. Biotechnol Appl Bioc 32 (Pt 2) : 95 107.
62. Harriott MM Noverr MC (2009) Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob Agents Ch 53 : 3914 3922.
63. Harrison JJ, Turner RJ Ceri H (2005) Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa. Environ Microbiol 7 : 981 994.
64. Hensel M, Shea JE, Gleeson C, Jones MD, Dalton E Holden DW (1995) Simultaneous identification of bacterial virulence genes by negative selection. Science 269 : 400 403.
65. Hiller NL, Janto B, Hogg JS et al 2007) Comparative genomic analyses of seventeen Streptococcus pneumoniae strains: insights into the pneumococcal supragenome. J Bacteriol 189 : 8186 8195.
66. Hogan DA, Vik A Kolter R (2004) A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol 54 : 1212 1223.
67. Hogg JS, Hu FZ, Janto B et al 2007) Characterization and modeling of the Haemophilus influenzae core and supragenomes based on the complete genomic sequences of Rd and 12 clinical nontypeable strains. Genome Biol 8 : R103 R103.18.
68. Holtfreter S, Nguyen TT, Wertheim H et al 2009) Human immune proteome in experimental colonization with Staphylococcus aureus. Clin Vaccine Immunol 16 : 1607 1614.
69. Hu DL, Narita K, Hyodo M, Hayakawa Y, Nakane A Karaolis DK (2009) c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection. Vaccine 27 : 4867 4873.
70. Hudecz F (2001) Manipulation of epitope function by modification of peptide structure: a minireview. Biologicals 29 : 197 207.
71. Joyce JG, Abeygunawardana C, Xu Q et al 2003) Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus. Carbohyd Res 338 : 903 922.
72. Kaplan JB, Velliyagounder K, Ragunath C, Rohde H, Mack D, Knobloch JK Ramasubbu N (2004) Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans and Actinobacillus pleuropneumoniae biofilms. J Bacteriol 186 : 8213 8220.
73. Karaolis DK, Means TK, Yang D et al 2007) Bacterial c-di-GMP is an immunostimulatory molecule. J Immunol 178 : 2171 2181.
74. Kaushik DK Sehgal D (2008) Developing antibacterial vaccines in genomics and proteomics era. Scand J Immunol 67 : 544 552.
75. Ketley JM, Michalski J, Galen J, Levine MM Kaper JB (1993) Construction of genetically marked Vibrio cholerae O1 vaccine strains. FEMS Microbiol Lett 111 : 15 21.
76. Kim HK, Dedent A, Cheng AG, McAdow M, Bagnoli F, Missiakas DM Schneewind O (2010) IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge. Vaccine DOI :.
77. Klotz SA, Chasin BS, Powell B, Gaur NK Lipke PN (2007) Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn Micr Infec Dis 59 : 401 406.
78. Knobloch JK, Horstkotte MA, Rohde H Mack D (2002) Evaluation of different detection methods of biofilm formation in Staphylococcus aureus. Med Microbiol Immun 191 : 101 106.
79. Korsholm KS, Petersen RV, Agger EM Andersen P (2010) T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection. Immunology 129 : 75 86.
80. Kuramitsu HK, He X, Lux R, Anderson MH Shi W (2007) Interspecies interactions within oral microbial communities. Microbiol Mol Biol R 71 : 653 670.
81. Levine MM Kaper JB (1993) Live oral vaccines against cholera: an update. Vaccine 11 : 207 212.
82. Lewis K (2008) Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol 322 : 107 131.
83. Liljeqvist S Stahl S (1999) Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. J Biotechnol 73 : 1 33.
84. Lin L, Ibrahim AS, Baquir B, Avanesian V, Fu Y Spellberg B (2009) Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus. FEMS Immunol Med Mic 55 : 293 295.
85. Lopez AL, Clemens JD, Deen J Jodar L (2008) Cholera vaccines for the developing world. Hum Vaccin 4 : 165 169.
86. Lowe AM, Beattie DT Deresiewicz RL (1998) Identification of novel staphylococcal virulence genes by in vivo expression technology. Mol Microbiol 27 : 967 976.
87. Mader JT Shirtliff M (1999) The rabbit model of bacterial osteomyelitis of the tibia. Handbook of Animal Models of Infection (Zak O Sande MA, eds), pp. 581 591. Academic Press Ltd
88. Mahan MJ, Slauch JM Mekalanos JJ (1993) Selection of bacterial virulence genes that are specifically induced in host tissues. Science 259 : 686 688.
89. Maira-Litran T, Kropec A, Goldmann DA Pier GB (2005) Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun 73 : 6752 6762.
90. Martin-Lopez JV, Perez-Roth E, Claverie-Martin F, Diez Gil O, Batista N, Morales M Mendez-Alvarez S (2002) Detection of Staphylococcus aureus clinical isolates harboring the ica gene cluster needed for biofilm establishment. J Clin Microbiol 40 : 1569 1570.
91. McKenney D, Hubner J, Muller E, Wang Y, Goldmann DA Pier GB (1998) The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun 66 : 4711 4720.
92. McKenney D, Pouliot KL, Wang Y et al 1999) Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science 284 : 1523 1527.
93. McKenney D, Pouliot K, Wang Y et al 2000) Vaccine potential of poly-1-6 beta-d-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. J Biotechnol 83 : 37 44.
94. Mei JM, Nourbakhsh F, Ford CW Holden DW (1997) Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis. Mol Microbiol 26 : 399 407.
95. Meinke A, Henics T, Hanner M, Minh DB Nagy E (2005) Antigenome technology: a novel approach for the selection of bacterial vaccine candidate antigens. Vaccine 23 : 2035 2041.
96. Mufson MA, Hughey D Lydick E (1985) Type-specific antibody responses of volunteers immunized with 23-valent pneumococcal polysaccharide vaccine. J Infect Dis 151 : 749 750.
97. Murphy TF, Kirkham C, Sethi S Lesse AJ (2005) Expression of a peroxiredoxin-glutaredoxin by Haemophilus influenzae in biofilms and during human respiratory tract infection. FEMS Immunol Med Mic 44 : 81 89.
98. Musser JM (2006) The next chapter in reverse vaccinology. Nat Biotechnol 24 : 157 158.
99. Nandakumar R, Nandakumar MP, Marten MR Ross JM (2005) Proteome analysis of membrane and cell wall associated proteins from Staphylococcus aureus. J Proteome Res 4 : 250 257.
100. Nickel JC, Emtage J Costerton JW (1985a) Ultrastructural microbial ecology of infection-induced urinary stones. J Urology 133 : 622 627.
101. Nickel JC, Ruseska I, Wright JB Costerton JW (1985b) Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Ch 27 : 619 624.
102. Nickel JC, Heaton J, Morales A Costerton JW (1986a) Bacterial biofilm in persistent penile prosthesis-associated infection. J Urology 135 : 586 588.
103. Nickel JC, Reid G, Bruce AW Costerton JW (1986b) Ultrastructural microbiology of infected urinary stone. Urology 28 : 512 515.
104. Nickel JC, Downey JA Costerton JW (1989) Ultrastructural study of microbiologic colonization of urinary catheters. Urology 34 : 284 291.
105. Ogra PL, Faden H Welliver RC (2001) Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 14 : 430 445.
106. Olson ME, Garvin KL, Fey PD Rupp ME (2006) Adherence of Staphylococcus epidermidis to biomaterials is augmented by PIA. Clin Orthop Relat R 451 : 21 24.
107. O'May GA, Jacobsen SM, Longwell M, Stoodley P, Mobley HL Shirtliff ME (2009) The high-affinity phosphate transporter Pst in Proteus mirabilis HI4320 and its importance in biofilm formation. Microbiology 155 : 1523 1535.
108. Parise G, Mishra M, Itoh Y, Romeo T Deora R (2007) Role of a putative polysaccharide locus in Bordetella biofilm development. J Bacteriol 189 : 750 760.
109. Perez MM, Prenafeta A, Valle J et al 2009) Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl beta-1,6 glucosamine specific antibody production using biofilm-embedded bacteria. Vaccine 27 : 2379 2386.
110. Perez-Melgosa M, Ochs HD, Linsley PS et al 2001) Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine. Eur J Immunol 31 : 2373 2381.
111. Pichichero ME, DeTora LM Johnson DR (2006) An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine. Expert Rev Vaccines 5 : 175 187.
112. Plotkin SA, Orenstein WA Offit PA (2008) Vaccines. Saunders
113. Post JC, Aul JJ, White GJ et al 1996) PCR-based detection of bacterial DNA after antimicrobial treatment is indicative of persistent, viable bacteria in the chinchilla model of otitis media. Am J Otolaryng 17 : 106 111.
114. Rappuoli R (2000) Reverse vaccinology. Curr Opin Microbiol 3 : 445 450.
115. Riley ID, Tarr PI, Andrews M, Pfeiffer M, Howard R, Challands P Jennison G (1977) Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community. Lancet 1 : 1338 1341.
116. Robbins JB, Austrian R, Lee CJ et al 1983) Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 148 : 1136 1159.
117. Roberts FJ (1989) Definition of polymicrobial bacteremia. Rev Infect Dis 11 : 1029 1030.
118. Rodriguez-Ortega MJ, Norais N, Bensi G et al 2006) Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat Biotechnol 24 : 191 197.
119. Rohde H, Knobloch JK, Horstkotte MA Mack D (2001) Correlation of Staphylococcus aureus icaADBC genotype and biofilm expression phenotype. J Clin Microbiol 39 : 4595 4596.
120. Rollenhagen C, Sorensen M, Rizos K, Hurvitz R Bumann D (2004) Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen. P Natl Acad Sci USA 101 : 8739 8744.
121. Rupp ME, Ulphani JS, Fey PD Mack D (1999) Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model. Infect Immun 67 : 2656 2659.
122. Sadarangani M Pollard AJ (2010) Serogroup B meningococcal vaccines - an unfinished story. Lancet Infect Dis 10 : 112 124.
123. National Institutes of Health (NHLBI, NIDCR, NIAID, NIDCD, NIAMS, NIGMS, NIDDK, NICHD, NINR, and ORWH) (1999) SBIR/STTR Study and control of microbial biofilms (PA-99-084) (). Release date: April 21, 1999.
124. Schaffer AC Lee JC (2008) Vaccination and passive immunisation against Staphylococcus aureus. Int J Antimicrob Ag 32 (suppl 1) : S71 S78.
125. Serruto D Rappuoli R (2006) Post-genomic vaccine development. FEBS Lett 580 : 2985 2992.
126. Serruto D, Serino L, Masignani V Pizza M (2009) Genome-based approaches to develop vaccines against bacterial pathogens. Vaccine 27 : 3245 3250.
127. Shen K, Antalis P, Gladitz J et al 2005) Identification, distribution, and expression of novel genes in 10 clinical isolates of nontypeable Haemophilus influenzae. Infect Immun 73 : 3479 3491.
128. Shirtliff ME Mader JT (2000) Osteomyelitis: Clinical Features and Molecular Aspects of Persistence. ASM Press
129. Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, Rabin HR Surette MG (2008) Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog 4 : e1000184.
130. Slutter B, Hagenaars N Jiskoot W (2008) Rational design of nasal vaccines. J Drug Target 16 : 1 17.
131. Solis N, Larsen MR Cordwell SJ (2010) Improved accuracy of cell surface shaving proteomics in Staphylococcus aureus using a false-positive control. Proteomics 10 : 2037 2049.
132. Spellberg B, Ibrahim AS, Yeaman MR et al 2008) The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus. Infect Immun 76 : 4574 4580.
133. Stecher B Hardt WD (2008) The role of microbiota in infectious disease. Trends Microbiol 16 : 107 114.
134. Stewart PS Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358 : 135 138.
135. Stoodley P, Kathju S, Hu FZ et al 2005) Molecular and imaging techniques for bacterial biofilms in joint arthroplasty infections. Clin Orthop Relat R 437 : 31 40.
136. Stranger-Jones YK, Bae T Schneewind O (2006) Vaccine assembly from surface proteins of Staphylococcus aureus. P Natl Acad Sci USA 103 : 16942 16947.
137. National Institutes of Health (NIDCR, NIAID) (1998) Targeted research on oral microbial biofilms (DE-98-006) (). Release date: March 6, 1998.
138. Tarsia P, Aliberti S, Pappalettera M Blasi F (2007) Mixed community-acquired lower respiratory tract infections. Curr Infect Dis Rep 9 : 14 20.
139. Tettelin H, Masignani V, Cieslewicz MJ et al 2002) Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. P Natl Acad Sci USA 99 : 12391 12396.
140. Tettelin H, Masignani V, Cieslewicz MJ et al 2005) Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial 'pan-genome'. P Natl Acad Sci USA 102 : 13950 13955.
141. Thompson EA, Feavers IM Maiden MC (2003) Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology 149 : 1849 1858.
142. Trotter CL, McVernon J, Ramsay ME et al 2008) Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine 26 : 4434 4445.
143. Tugyi R, Mezo G, Gitta S, Fellinger E, Andreu D Hudecz F (2008) Effect of conjugation with polypeptide carrier on the enzymatic degradation of Herpes simplex virus glycoprotein D derived epitope peptide. Bioconjugate Chem 19 : 1652 1659.
144. Tuomanen E (1986) Piracy of adhesins: attachment of superinfecting pathogens to respiratory cilia by secreted adhesins of Bordetella pertussis. Infect Immun 54 : 905 908.
145. Uddowla S, Freytag LC Clements JD (2007) Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens. Vaccine 25 : 7984 7993.
146. Vajdy M (2006) Generation and maintenance of mucosal memory B cell responses? Curr Med Chem 13 : 3023 3037.
147. Valdivia RH Falkow S (1996) Bacterial genetics by flow cytometry: rapid isolation of Salmonella typhimurium acid-inducible promoters by differential fluorescence induction. Mol Microbiol 22 : 367 378.
148. Valensi JP, Carlson JR Van Nest GA (1994) Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. J Immunol 153 : 4029 4039.
149. Viale P Stefani S (2006) Vascular catheter-associated infections: a microbiological and therapeutic update. J Chemotherapy 18 : 235 249.
150. Vuong C, Kocianova S, Voyich JM, Yao Y, Fischer ER, DeLeo FR Otto M (2004) A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem 279 : 54881 54886.
151. Vytvytska O, Nagy E, Bluggel M, Meyer HE, Kurzbauer R, Huber LA Klade CS (2002) Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics 2 : 580 590. (Pubitemid 34507348)
152. Wack A, Baudner BC, Hilbert AK et al 2008) Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice. Vaccine 26 : 552 561.
153. Wahdan MH, Serie C, Germanier R et al 1980) A controlled field trial of liver oral typhoid vaccine Ty21a. B World Health Organ 58 : 469 474.
154. Waite RD, Paccanaro A, Papakonstantinopoulou A, Hurst JM, Saqi M, Littler E Curtis MA (2006) Clustering of Pseudomonas aeruginosa transcriptomes from planktonic cultures, developing and mature biofilms reveals distinct expression profiles. BMC Genomics 7 : 162.
155. Wang X, Preston JF 3rd. Romeo T (2004) The pgaABCD locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. J Bacteriol 186 : 2724 2734.
156. Zagursky RJ Anderson AS (2008) Application of genomics in bacterial vaccine discovery: a decade in review. Curr Opin Pharmacol 8 : 632 638.
157. Zecconi A, Binda E, Borromeo V Piccinini R (2005) Relationship between some Staphylococcus aureus pathogenic factors and growth rates and somatic cell counts. J Dairy Res 72 : 203 208.
158. Ziebuhr W, Heilmann C, Gotz F, Meyer P, Wilms K, Straube E Hacker J (1997) Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun 65 : 890 896.
159. Zorzeto TQ, Higashi HG, da Silva MT et al 2009) Immunogenicity of a whole-cell pertussis vaccine with low lipopolysaccharide content in infants. Clin Vaccine Immunol 16 : 544 550.